Siraj Ali
Overview
Explore the profile of Siraj Ali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
2022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Devlin C, Tomov M, Chen H, Nama S, Ali S, Neelakantan S, et al.
Front Cardiovasc Med
. 2024 Jul;
11:1432784.
PMID: 39026997
Introduction: Primary pulmonary vein stenosis (PVS) is a rare congenital heart disease that proves to be a clinical challenge due to the rapidly progressive disease course and high rates of...
2.
Lee L, Ali S, Genega E, Reed D, Sokol E, Mathew P
JCO Precis Oncol
. 2022 Feb;
2:1-8.
PMID: 35135110
No abstract available.
3.
Drilon A, Duruisseaux M, Han J, Ito M, Falcon C, Yang S, et al.
J Clin Oncol
. 2021 Jun;
39(25):2791-2802.
PMID: 34077268
Purpose: Although fusions are oncogenic drivers across multiple tumor types including lung cancers, these are difficult to study because of their rarity. The global eNRGy1 registry was thus established to...
4.
Thomas A, Mian I, Tlemsani C, Pongor L, Takahashi N, Maignan K, et al.
Chest
. 2020 May;
158(4):1723-1733.
PMID: 32464188
Background: Small cell lung cancer (SCLC) has the strongest association with smoking among lung cancers. The characteristics of never smokers with SCLC is not known. Research Question: Are the clinical...
5.
Hoffman-Censits J, Choi W, Pal S, Trabulsi E, Kelly W, Hahn N, et al.
Eur Urol Oncol
. 2020 Feb;
4(2):297-300.
PMID: 32061548
Although predominantly urothelial, some bladder cancer and upper tract urothelial cancer (BC/UTUC) harbor histologic variants. Small cell BC (SCBC) variants comprised ˜5% of The Cancer Genome Atlas BC cohort, with...
6.
Serebriiskii I, Connelly C, Frampton G, Newberg J, Cooke M, Miller V, et al.
Nat Commun
. 2019 Aug;
10(1):3722.
PMID: 31427573
Colorectal cancer (CRC) is increasingly appreciated as a heterogeneous disease, with factors such as microsatellite instability (MSI), cancer subsite within the colon versus rectum, and age of diagnosis associated with...
7.
Chu L, Franck D, Parachoniak C, Gregg J, Moore M, Farwell D, et al.
Oncologist
. 2019 Aug;
24(10):1305-1308.
PMID: 31391294
Identification of effective targeted therapies for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains an unmet medical need. A patient with platinum-refractory recurrent oral cavity HNSCC underwent comprehensive genomic...
8.
Brown B, Zhang Y, Westover D, Yan Y, Qiao H, Huang V, et al.
Clin Cancer Res
. 2019 Feb;
25(11):3341-3351.
PMID: 30796031
Purpose: The third-generation EGFR inhibitor, osimertinib, is the first mutant-selective inhibitor that has received regulatory approval for the treatment of patients with -mutant lung cancer. Despite the development of highly...
9.
Goldberg M, Montesion M, Young L, Suh J, Greenbowe J, Kennedy M, et al.
PLoS One
. 2018 Nov;
13(11):e0208097.
PMID: 30481207
After sequential treatment with first- and third-generation EGFR tyrosine kinase inhibitors (TKIs), EGFR-mutant non-small cell lung cancers frequently harbor multiple resistance mutations in exon 20 of EGFR including T790M, mediating...
10.
Juckett L, Lin D, Madison R, Ross J, Schrock A, Ali S
Oncology
. 2018 Nov;
96(2):101-109.
PMID: 30380541
Background: The Polycomb Repressive Complex 1 (PRC1) regulates epigenetic silencing and is manifestly linked to rare cancer types. The X-linked BCOR gene (BCL-6 Corepressor) is a member of the PRC1...